Series date: 
01/01/2023 - 6:00am CST to 12/31/2023 - 11:59pm CST

OBJECTIVES: Upon completion of this activity, the participant should be able to:   (1) Identify the appropriate NCCN and ASH guidelines, (2) Recognize common presenting symptoms and understand treatment modalities for patients with leukemia.  (3) Analyze clinical trials available for leukemic patients through the Baylor Research Institute.

PLANNER/MODERATOR DISCLOSURE:  Charles Buess, MD, has no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Taylor Martinez at [email protected]

 

 

Series location: 
Baylor Charles A. Sammons Cancer Center - Dallas Campus
3410 Worth Street Ste 580
Dallas, TX 75246
United States

Sessions

Session Date
20230524 Dallas Hematology/Oncology Disease TB 05/24/2023 - 12:30pm to 1:30pm CDT
20230531 Dallas Hematology/Oncology Disease TB 05/31/2023 - 12:30pm to 1:30pm CDT
CANCELLED 20230607 Dallas Hematology/Oncology Disease TB 06/07/2023 - 12:30pm to 1:30pm CDT
20230614 Dallas Hematology/Oncology Disease TB 06/14/2023 - 12:30pm to 1:30pm CDT
CANCELLED - 20230621 Dallas Hematology/Oncology Disease TB 06/21/2023 - 12:30pm to 1:30pm CDT
20230628 Dallas Hematology/Oncology Disease TB 06/28/2023 - 12:30pm to 1:30pm CDT
20230705 Dallas Hematology/Oncology Disease TB 07/05/2023 - 12:30pm to 1:30pm CDT
20230712 Dallas Hematology/Oncology Disease TB 07/12/2023 - 12:30pm to 1:30pm CDT
20230719 Dallas Hematology/Oncology Disease TB 07/19/2023 - 12:30pm to 1:30pm CDT
20230726 Dallas Hematology/Oncology Disease TB 07/26/2023 - 12:30pm to 1:30pm CDT

Pages